Evidence map›Paper›PMID 33633000›Full record

ArticleThe Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi2021

Retreatment of Chronic Hepatitis C Failed to Daclatasvir Plus Asunaprevir by Other Direct-acting Antivirals.

Dong Hoon Lee, Soo Hyung Ryu, Hee Jun Myung, Yun Jae Shin, Si Hyeong Lee, Tae Young Park, Jeong Seop Moon

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Dong Hoon LeeDepartment of Internal Medicine, Seoul Paik Hospital, Inje University College of Medicine, Seoul, Korea.
Soo Hyung RyuDepartment of Internal Medicine, Seoul Paik Hospital, Inje University College of Medicine, Seoul, Korea.ORCID 0000-0002-1654-7057
Hee Jun MyungDepartment of Internal Medicine, Seoul Paik Hospital, Inje University College of Medicine, Seoul, Korea.
Yun Jae ShinDepartment of Internal Medicine, Seoul Paik Hospital, Inje University College of Medicine, Seoul, Korea.
Si Hyeong LeeDepartment of Internal Medicine, Seoul Paik Hospital, Inje University College of Medicine, Seoul, Korea.
Tae Young ParkDepartment of Internal Medicine, Seoul Paik Hospital, Inje University College of Medicine, Seoul, Korea.
Jeong Seop MoonDepartment of Internal Medicine, Seoul Paik Hospital, Inje University College of Medicine, Seoul, Korea.
Inje University Seoul Paik Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pegylated interferon plus ribavirin combination therapy has been used as the primary treatment for chronic hepatitis C (CHC) but fails to produce a sustained viral response (SVR) in many patients. In recent years, the treatment of CHC has been rapidly changing because of the introduction of direct-acting antivirals (DAAs), which have a high cure rate. However, retreatment of patients after failure of the first DAA therapy is difficult. We report two rare cases of CHC that showed acquired SVR with other DAA combinations after failure to daclatasvir and asunaprevir.

Indexed as

Antiviral AgentsDrug Therapy, CombinationHepatitis C, ChronicCarbamatesGenotypeHepacivirusHumansImidazolesIsoquinolinesPyrrolidinesRetreatmentSulfonamidesValineAntiviral AgentsasunaprevirCarbamatesdaclatasvirImidazolesIsoquinolinesPyrrolidinesSulfonamidesValineAntiviral agentsAsunaprevirchronicDaclatasvirHepatitis C

Identifiers

PMID33633000
PMCPMC12286463
OpenAlexW3129902154

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.